Market Overview

Zynerba Pharmaceuticals (NASDAQ: ZYNE)

6.31 -0.48 (-7.07%)

Analyst Ratings

DateResearch FirmActionCurrentPT
9/21/18Cantor FitzgeraldInitiates Coverage OnOverweight21.0
8/03/18Canaccord GenuityMaintainsBuy15.0
2/01/18H.C. WainwrightAssumesBuy23.0
1/29/18Ladenburg ThalmannInitiates Coverage OnBuy25.5
1/26/18Seaport GlobalInitiates Coverage OnBuy16.0
10/02/17Cantor FitzgeraldUpgradesOverweight
9/29/17Canaccord GenuityMaintainsBuy15.0
9/29/17PiperJaffrayUpgradesOverweight
8/21/17Canaccord GenuityMaintainsBuy9.0
8/15/17OppenheimerDowngradesMarket Perform

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter